Literature DB >> 16473490

A stability-indicating HPLC assay method for docetaxel.

B Mallikarjuna Rao1, Arpita Chakraborty, M K Srinivasu, M Lalitha Devi, P Rajender Kumar, K B Chandrasekhar, A K Srinivasan, A S Prasad, J Ramanatham.   

Abstract

A novel stability-indicating high-performance liquid chromatographic assay method was developed and validated for docetaxel in the presence of degradation products generated from forced decomposition studies. A gradient HPLC method was developed to separate the drug from the degradation products, using a Hichrom RPB HPLC column. Mixture of water and acetonitrile was used as mobile phase. The flow rate was 1.0 ml/min and the detection was done at 230 nm. Using the above method one can carry out the quantitative estimation of impurity namely DCT-1 and docetaxel. The developed gradient LC method was subsequently validated.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16473490     DOI: 10.1016/j.jpba.2006.01.011

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  8 in total

1.  Pharmacokinetic evaluation of three oral formulations of docetaxel boosted with ritonavir: two single-drug formulations vs. a fixed-dose combination tablet.

Authors:  Johannes J Moes; Frederik E Stuurman; Jeroen J M A Hendrikx; Serena Marchetti; Alwin D R Huitema; Jos H Beijnen; Jan H M Schellens; Bastiaan Nuijen
Journal:  Drug Deliv Transl Res       Date:  2013-06       Impact factor: 4.617

2.  Low-molecular-weight methylcellulose-based thermo-reversible gel/pluronic micelle combination system for local and sustained docetaxel delivery.

Authors:  Jang Kyoung Kim; Young-Wook Won; Kwang Suk Lim; Yong-Hee Kim
Journal:  Pharm Res       Date:  2011-09-09       Impact factor: 4.200

3.  Is an alternative drug delivery system needed for docetaxel? The role of controlling epimerization in formulations and beyond.

Authors:  Arehalli S Manjappa; Peeyush N Goel; Makam P Vekataraju; Kesarla S Rajesh; Kinjal Makwana; Mukesh Ukawala; Yuvraj Nikam; Rajiv P Gude; Rayasa S Ramachandra Murthy
Journal:  Pharm Res       Date:  2013-06-12       Impact factor: 4.200

4.  Evaluation of the pharmaceutical quality of docetaxel injection using new stability indicating chromatographic methods for assay and impurities.

Authors:  Annarapu Malleswara Reddy; Nagaraju Banda; Shinde Govind Dagdu; Dama Venugopala Rao; Chandra Sekhar Kocherlakota; Vyas Krishnamurthy
Journal:  Sci Pharm       Date:  2010-03-05

5.  Development of Polysorbate 80/Phospholipid mixed micellar formation for docetaxel and assessment of its in vivo distribution in animal models.

Authors:  Hua Song; Hongquan Geng; Jing Ruan; Kan Wang; Chenchen Bao; Juan Wang; Xia Peng; Xueqing Zhang; Daxiang Cui
Journal:  Nanoscale Res Lett       Date:  2011-04-20       Impact factor: 4.703

6.  Docetaxel-Loaded Nanoparticles Assembled from β-Cyclodextrin/Calixarene Giant Surfactants: Physicochemical Properties and Cytotoxic Effect in Prostate Cancer and Glioblastoma Cells.

Authors:  Laura Gallego-Yerga; Inmaculada Posadas; Cristina de la Torre; Jesús Ruiz-Almansa; Francesco Sansone; Carmen Ortiz Mellet; Alessandro Casnati; José M García Fernández; Valentín Ceña
Journal:  Front Pharmacol       Date:  2017-05-08       Impact factor: 5.810

Review 7.  Choices of chromatographic methods as stability indicating assays for pharmaceutical products: A review.

Authors:  Yik-Ling Chew; Mei-Ann Khor; Yau-Yan Lim
Journal:  Heliyon       Date:  2021-03-27

8.  Facile production of nanocomposites of carbon nanotubes and polycaprolactone with high aspect ratios with potential applications in drug delivery.

Authors:  Edyta Niezabitowska; Jessica Smith; Mark R Prestly; Riaz Akhtar; Felix W von Aulock; Yan Lavallée; Hanene Ali-Boucetta; Tom O McDonald
Journal:  RSC Adv       Date:  2018-05-04       Impact factor: 4.036

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.